Susquehanna Fundamental Investments, LLC Navidea Biopharmaceuticals, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$1.99 - $2.9 $65,315 - $95,183	-32,822 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$1.88 - $2.84 $35,392 - $53,465	-18,826 Reduced 36.45%	32,822 $71,000
Q3 2020 Nov 16, 2020	BUY	$2.69 - $4.95 $90,244 - $166,062	33,548 Added 185.35%	51,648 $139,000
Q2 2020 Aug 14, 2020	BUY	$0.7 - $4.16 $12,670 - $75,296	18,100 New	18,100 $71,000

10.4K

Ticker NAVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,150,900
Description
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.